Futami Ryouhei, Tajiri Takashi, Miyashita Masao, Maruyama Hiroshi, Makino Hiroshi, Nomura Tsutomu, Tateno Atsushi, Miyashita Tsuguhiro, Sasajima Koji
Dept. of Surgery I, Nippon Medical School.
Gan To Kagaku Ryoho. 2003 May;30(5):681-4.
A 51-year-old male was assessed as having esophageal squamous cell carcinoma with trachea invasion and cervical lymph node metastasis. After one course of chemotherapy using cisplatin (CDDP), 5-fluorouracil (5-FU) and Leucovorin (LV), the patient had progressive disease (PD) of the primary lesion and metastatic lymph nodes, and a side effect of severe nausea. One course of nedaplatin, 5-FU and LV combined with radiation was performed alternatively. The effect was evaluated as a partial response (PR) of the primary lesion and metastatic lymph nodes. There were no adverse side effects such as nausea or renal dysfunction except for pancytopenia of grade 2. Increased serum levels of vascular endothelial growth factor (s-VEGF) decreased after the chemoradiotherapy and increased again during continued radiotherapy alone. More information is needed as to whether changes in s-VEGF relate to the clinical effects of the treatment.
一名51岁男性被诊断为食管鳞状细胞癌伴气管侵犯和颈部淋巴结转移。在使用顺铂(CDDP)、5-氟尿嘧啶(5-FU)和亚叶酸钙(LV)进行一个疗程的化疗后,患者的原发灶和转移淋巴结出现疾病进展(PD),并伴有严重恶心的副作用。交替进行了一个疗程的奈达铂、5-FU和LV联合放疗。评估结果为原发灶和转移淋巴结部分缓解(PR)。除2级全血细胞减少外,未出现恶心或肾功能不全等不良副作用。化疗放疗后血清血管内皮生长因子(s-VEGF)水平升高,单纯持续放疗期间再次升高。关于s-VEGF的变化是否与治疗的临床效果相关,还需要更多信息。